IFP Advisors Inc grew its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 12.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 87,479 shares of the company's stock after purchasing an additional 9,756 shares during the period. IFP Advisors Inc's holdings in Procter & Gamble were worth $12,828,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. California State Teachers Retirement System raised its position in Procter & Gamble by 14,323.0% during the 2nd quarter. California State Teachers Retirement System now owns 516,914,798 shares of the company's stock worth $75,800,386,000 after buying an additional 513,330,829 shares during the last quarter. BlackRock Inc. purchased a new stake in shares of Procter & Gamble in the second quarter valued at about $27,862,105,000. Norges Bank acquired a new position in shares of Procter & Gamble during the fourth quarter worth about $4,664,783,000. Bank of America Corp DE acquired a new position in shares of Procter & Gamble during the second quarter worth about $3,850,628,000. Finally, Bank of New York Mellon Corp acquired a new stake in Procter & Gamble in the second quarter valued at about $2,281,505,000. Hedge funds and other institutional investors own 65.77% of the company's stock.
More Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: P&G remains a Dividend King, having increased its dividend for roughly seven decades. Fiscal 2026 revenue reportedly rose 3% to more than $87 billion, while Moody’s moved its credit outlook to positive, supporting confidence in the company’s balance sheet and shareholder-return capacity. 1 Stat That Makes Procter & Gamble Hard to Ignore This September
- Neutral Sentiment: PG continues to attract attention as a defensive consumer-staples investment and income stock. However, comparisons with other defensive blue chips highlight that safety alone has not guaranteed superior returns. Which Defensive Stock Has Dominated in 2026
- Negative Sentiment: Analysts warn that rising input costs, unfavorable foreign-exchange movements and other pressures could create an estimated $1.4 billion after-tax earnings headwind in fiscal 2027. The concern is especially significant because P&G’s latest quarter beat on earnings but missed revenue expectations, reinforcing questions about underlying growth. Procter & Gamble Margins Under Pressure
- Negative Sentiment: Jim Cramer described P&G as having little or no growth, a criticism that could weigh on the stock’s valuation near 22 times earnings. Investors appear increasingly focused on whether dependable dividends can compensate for sluggish sales and earnings expansion. Jim Cramer Discusses Procter & Gamble Valuation and Growth
Wall Street Analysts Forecast Growth
Several research firms have recently commented on PG. Jefferies Financial Group raised their price target on Procter & Gamble from $177.00 to $179.00 and gave the company a "buy" rating in a report on Friday, June 26th. Sanford C. Bernstein reiterated a "market perform" rating and issued a $149.00 price objective on shares of Procter & Gamble in a research report on Monday, August 24th. Bank of America reduced their target price on Procter & Gamble from $170.00 to $166.00 and set a "buy" rating for the company in a report on Friday, July 10th. Barclays boosted their target price on shares of Procter & Gamble from $146.00 to $152.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 21st. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Procter & Gamble in a research note on Wednesday, June 24th. Thirteen equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company's stock. According to MarketBeat.com, Procter & Gamble presently has a consensus rating of "Moderate Buy" and an average price target of $161.19.
View Our Latest Stock Report on PG
Procter & Gamble Price Performance
Shares of NYSE:PG opened at $145.59 on Wednesday. The firm has a market capitalization of $338.16 billion, a price-to-earnings ratio of 21.99, a price-to-earnings-growth ratio of 3.64 and a beta of 0.39. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.68 and a quick ratio of 0.47. The business's 50 day simple moving average is $146.71 and its 200-day simple moving average is $147.56. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $167.25.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.02. The firm had revenue of $21.20 billion during the quarter, compared to the consensus estimate of $21.38 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%.Procter & Gamble's quarterly revenue was up 1.5% on a year-over-year basis. During the same period last year, the business posted $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. As a group, equities analysts forecast that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 17th. Investors of record on Friday, July 24th were given a $1.0885 dividend. The ex-dividend date was Friday, July 24th. This represents a $4.35 annualized dividend and a dividend yield of 3.0%. Procter & Gamble's payout ratio is currently 65.71%.
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CAO Matthew Janzaruk sold 359 shares of the firm's stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $145.24, for a total transaction of $52,141.16. Following the completion of the transaction, the chief accounting officer directly owned 1,271 shares in the company, valued at approximately $184,600.04. This trade represents a 22.02% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Susan Whaley sold 2,238 shares of Procter & Gamble stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $143.79, for a total transaction of $321,802.02. Following the transaction, the insider owned 26,989 shares of the company's stock, valued at approximately $3,880,748.31. The trade was a 7.66% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders have sold 6,627 shares of company stock valued at $953,417. Insiders own 0.23% of the company's stock.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Company is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio spans beauty, grooming, health care, fabric and home care, and family care products.
The company's brands include Tide, Ariel, Downy, Dawn, Febreze, Bounty, Charmin, Pampers, Gillette, Oral-B, Crest, Head & Shoulders, Olay and Pantene. These products are sold through retailers, e-commerce platforms and other distribution channels.
Procter & Gamble was founded in Cincinnati in 1837 by William Procter and James Gamble.
Featured Stories
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.